Ac-IETD-CHO

Catalog No.: C007B-549360
Mfr. No.: C344006-25mg
Mfr. Name: Aladdin Scientific
Qty/UOM: 1
UOM: EA

Price: $1,757.31

List Price: $1,952.57

Ac-IETD-CHO is a potent, reversible inhibitor of granzyme B and caspase-8. Ac-IETD-CHO inhibits Fas-mediated apoptotic cell death, hemorrhage, and liver failure.

Enjoy exclusive benefits including discounted pricing on orders by contacting our Sales Executives to open an account. Contact Us

Current Stock:

Quantity:

Adding to cart… The item has been added

Description
Specifications

Ac-IETD-CHO is a potent, reversible inhibitor of granzyme B and caspase-8. Ac-IETD-CHO inhibits Fas-mediated apoptotic cell death, hemorrhage, and liver failure. Ac-IETD-CHO also inhibits cytotoxic T lymphocytes induced cell death.

Specification: ≥95%

Molecular Formula: C21H34N4O10

Molecular Weight: 502.52

PubChem CID: 11466200

Isomeric SMILES: CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(=O)O)C=O)NC(=O)C

Related Documents: https://ald-pub-files.oss-cn-shanghai.aliyuncs.com/aladdinsci/pdp/sds/1/C344006-SCI_384ce016fbae42255fe7eec4567c1364.pdf

UPC:: 51131822
Condition:: New
Availability:: 5-10 days
Weight:: 0.07 Ounces
HazmatClass:: No
WeightUOM:: LB
MPN:: C344006-25mg
CAS:: 191338-86-0
Product Size:: 25mg
Precautionary Statement Codes:: P264

Cenmed Satisfaction Guarantee

At Cenmed, your confidence and satisfaction are paramount. We guarantee the quality and reliability of our extensive range of clinical and laboratory supplies. If you're not completely satisfied with your purchase, we offer a straightforward return process and dedicated support to resolve your concerns promptly. Our commitment ensures that you can order with confidence, knowing that Cenmed is dedicated to superior service and customer satisfaction. Trust us to meet your needs with every order, backed by our promise of excellence. Learn more in Help & FAQs.

"Cenmed provides me access to the same products/services normally reserved for much larger labs than mine. I was presently surprised by their product offering."